Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Are peptides legal in Arizona?

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

The short answer

Yes. An Arizona resident can obtain FDA approved peptides such as semaglutide and tirzepatide by prescription from an Arizona-licensed provider or from an out-of-state provider registered under A.R.S. 36-3606, including by telehealth under A.R.S. 36-3601 through 36-3607 (HB 2454, 2021), and can obtain a compounded peptide when it is eligible under federal 503A rules and dispensed by an Arizona-permitted pharmacy or a nonresident pharmacy holding an Arizona nonresident permit. Arizona is one of the more open telehealth states: the statute covers asynchronous care and lets qualifying out-of-state providers register instead of obtaining a full Arizona license.

Regulatory: Telehealth allowedRegulatory: Async allowedRegulatory: Compounded GLP-1 limitedVerified: Verified Oct 28, 2026
Compounding rules
Follows the federal 503A framework
Telehealth prescribing
Allowed, asynchronous allowed
Compounded GLP-1
Limited

Can a Arizona resident get peptides by telehealth?

A.R.S. 36-3601 defines telehealth as the interactive use of audio, video or other electronic media, including asynchronous store-and-forward technologies and remote patient monitoring, and excludes fax, instant messages, voicemail and email. A.R.S. 36-3602 requires informed consent before telehealth care and bars any health care board from requiring an in-person examination before a prescription is issued, except that Schedule II drugs may be prescribed only after an in-person or audio-visual examination. For physicians, A.R.S. 32-1401(27)(tt) makes it unprofessional conduct to prescribe without first conducting a physical or mental health status examination or having an established relationship, and says that examination may be conducted through telehealth as defined in section 36-3601 with a clinical evaluation appropriate for the patient and the condition. Under A.R.S. 36-3606 a provider licensed in another state may treat Arizona patients by telehealth after registering with the comparable Arizona board, provided the license is unrestricted, the provider carries liability coverage, follows Arizona prescribing law, and registers with the prescription monitoring program before prescribing a controlled substance. Peptides in this database are not controlled. The statutes do not mention online questionnaires. This record classifies asynchronous prescribing as allowed because the statutory telehealth definition expressly includes asynchronous store-and-forward technologies and the physician practice act lets the examination required before prescribing be done through telehealth as so defined. An exchange by email or instant message alone does not count as telehealth. [4] [5] [6] [7]

How does the Arizona pharmacy board treat compounding?

Compounding regulator for Arizona
BoardArizona State Board of Pharmacy
Eligible substancesFollows the federal 503A framework

The Arizona State Board of Pharmacy regulates compounding through Administrative Code rule R4-23-410 (current good compounding practices) and R4-23-670 (sterile pharmaceutical products), both of which require compliance with applicable federal law, so peptide eligibility follows the federal 503A framework (approved drug component, USP or NF monograph, or FDA 503A bulks list). Arizona has no state bulks list. A pharmacy located outside Arizona may not ship prescription-only drugs into the state without a Board-issued nonresident pharmacy permit under rule R4-23-607 and A.R.S. 32-1931, in addition to a valid permit in its home jurisdiction. The Board maintains a public license verification tool for both resident and nonresident pharmacies. [1] [2] [3] [8]

Can you get compounded GLP-1s in Arizona?

Regulatory: Compounded GLP-1 limited

Arizona patients using telehealth GLP-1 programs should confirm that the prescriber is Arizona-licensed or registered under A.R.S. 36-3606 and that the dispensing pharmacy holds an Arizona nonresident permit. [3] [7] [11]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in Arizona?

Access options

We may earn a commission from these links.

Prices are the partner's own and are not verified by PeptideAgent. You answer health questions after checkout, and the partner's clinician decides whether to prescribe.

Unsponsored access paths are checked against public regulatory records. Sponsored offers are the partner's and are labeled. Products labeled research use only are never listed.

Find a provider in Arizona

What you'll actually find in Arizona, and how to check

Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. [15] [16] [17]

No FDA oversight of the specific product: FDA does not check a compounded drug's safety, effectiveness, or quality before it is sold. [18]

What Arizona has done

PeptideAgent has not found a board or legislative action on peptides in Arizona.

Other states have acted:

  • On August 19, 2026, Mississippi's medical, nursing, and pharmacy boards said no licensed provider may prescribe, recommend, supply, or administer a peptide that is not FDA approved, and that a consent form does not remove the provider's liability. [20] Mississippi law
  • Louisiana acted by statute: Act 374, in effect August 1, 2026, bars its licensing boards from prohibiting peptides only when they come from a pharmacy or outsourcing facility that complies with federal compounding law. It does not make any peptide eligible to compound. [21] [22] Louisiana law

Checking the prescriber

Telehealth prescribing of non-controlled peptides is permitted in Arizona. A prescriber may prescribe without a live visit (asynchronous care) when it meets the standard of care. [4] [5] [6] [7] The telehealth rule in full.

Checking the pharmacy

Look the pharmacy up yourself before you pay, including an out-of-state mail-order pharmacy. The pharmacy regulator is the Arizona State Board of Pharmacy; its license search: FDA BeSafeRx: state board of pharmacy license lookups. [19]

If you're going ahead anyway

These steps lower some risks. They do not make a compounded product safe, and FDA has not reviewed it. [18]

They do not change a peptide's legal status either. That depends on the peptide: for a withdrawn nomination such as BPC-157 or TB-500, a 503A pharmacy has no federal basis to compound it from bulk, with or without a prescription, while a few Category 1 substances, such as NAD+ and glutathione, are compounded under FDA's interim policy, with conditions. Each peptide page gives its status. [9] [23] [24]

Check the pharmacy's license. Look the pharmacy up yourself on your state board of pharmacy's license search; FDA's BeSafeRx page links every state's. If the pharmacy is not listed, or is not licensed in your state, do not use it. [19] [25] [26]

What a legitimate prescription and consult look like. Federal law lets a pharmacy compound only for an identified patient on a valid prescription. A legitimate prescriber is licensed in the state where you are, evaluates you, and tells you the drug is compounded and not FDA approved, and a telehealth company should say which pharmacy compounds it. A seller that needs no prescription, or a pharmacy with no pharmacist to answer questions, is a warning sign. [17] [26] [27]

Why this is safer than a research-use-only product. A state-licensed pharmacy answers to its state board and has a pharmacist you can reach. A product labeled "research use only" or "not for human consumption" has neither, and FDA treats such products sold for people as unapproved drugs. In a 2024 study of semaglutide sold online without a prescription, half of six orders never arrived, and every vial that did was rated probably substandard or falsified, held more drug than its label said, and contained endotoxin. Black-market growth peptides have also contained modified molecules the label did not name. Safer is not safe: compounded drugs can also be contaminated or have too much or too little active ingredient. [18] [28] [29] [30] [31] [32]

Check for:

  • A 503A pharmacy licensed in your state (your state board of pharmacy publishes license lookups). [18]
  • A real evaluation by a licensed prescriber, not just an online form.
  • A certificate of analysis for the specific batch.

Questions to ask

  • Pharmacy: What is your license number, and are you licensed in my state? Then check it yourself on the state board's site. [19]
  • Telehealth company: Which pharmacy compounds and ships this, and is it a 503A pharmacy or a 503B outsourcing facility? [17]
  • Pharmacy: Is this made for me on a prescription written in my name? [27]
  • Prescriber: Are you licensed where I am, and will you evaluate me yourself rather than rely on a questionnaire? [17] [26]
  • Anyone offering it: Does anyone call it "FDA approved", "generic", or from an "FDA-approved pharmacy"? None of these is true of a compounded drug, so the claim is a red flag. [17]

What is offered for a specific peptide, and what FDA found, is on each peptide page.

Is it legal to buy research peptides in Arizona?

A.R.S. 32-1931 and rule R4-23-607 prohibit a nonresident from selling or distributing prescription-only drugs into Arizona without a Board nonresident permit, and "research use only" peptides marketed for injection are unapproved new drugs under 21 U.S.C. 331 regardless of labeling. [3] [12]

Peptide-specific notes for Arizona

No peptide-specific rule identified for this jurisdiction. The general compounding and telehealth rules above apply, and the federal record covers semaglutide, tirzepatide, and BPC-157.

Frequently asked questions

Can I get a GLP-1 prescription in Arizona through telehealth without seeing a doctor in person?

Yes. A.R.S. 36-3602(E) bars Arizona health care boards from requiring an in-person examination before a prescription is issued, except for Schedule II drugs and where federal law requires one, and the definition of telehealth in A.R.S. 36-3601 includes asynchronous store-and-forward technologies. An Arizona-licensed or Arizona-registered provider may evaluate you remotely and prescribe semaglutide or tirzepatide, which are not controlled substances. An exchange by email or instant message alone does not count as telehealth. [5] [6] [7]

Can an out-of-state telehealth provider treat me in Arizona without an Arizona license?

Yes, if the provider has registered with the relevant Arizona licensing board under A.R.S. 36-3606, holds an unrestricted license in another state, carries liability coverage, and follows Arizona prescribing rules. Registered providers cannot open an Arizona office unless they are part of a multistate provider group that includes at least one Arizona-licensed provider. Check the board's registration list before paying. [7]

How do I check whether a mail-order pharmacy can ship compounded peptides to Arizona?

Search the Arizona State Board of Pharmacy license verification for the pharmacy. Rule R4-23-607 and A.R.S. 32-1931 require a nonresident pharmacy permit before any prescription-only drug is shipped into Arizona. If the pharmacy is not listed, the shipment is unlawful. [1] [3]

Can an Arizona pharmacy compound BPC-157 or other unapproved peptides?

Only under a draft federal policy, and only within strict limits. On October 28, 2026 HHS released a draft enforcement discretion policy saying it will not take enforcement action against a state-licensed pharmacy that compounds BPC-157 as a single-ingredient product by an allowed route, on a patient-specific prescription, from an FDA-registered manufacturer's substance with a tested certificate of analysis, with serious adverse events reported to FDA. BPC-157 is still not FDA approved or on the 503A bulks list, the policy is not binding and HHS may revisit it, and blends such as Wolverine are not covered. FDA's drug center recommended against listing BPC-157; the advisory committee voted in favor (HHS policy, Appendix B). The draft covers only six single peptides (BPC-157, epitalon, KPV, MOTS-c, semax, TB-500); others, such as CJC-1295 and ipamorelin, are not covered. State law still applies: Arizona has no state bulks list, and Board rules R4-23-410 and R4-23-670 require compliance with applicable federal law. [2] [9] [10] [13] [14]

Is it legal to buy research peptides online and ship them to Arizona?

No. Distributing prescription-only drugs into Arizona without a nonresident permit violates A.R.S. 32-1931, and "research use only" peptides sold for injection are unapproved drugs under federal law. They are not dispensed by a pharmacist. [3] [12]

From the blog

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, federal FDA guidance, and the FDA warning letters and studies behind what is offered.

  1. [1]Arizona State Board of Pharmacy
  2. [2]Arizona Administrative Code R4-23-410, Current good compounding practices
  3. [3]Arizona Administrative Code R4-23-607, Nonresident permits (implementing A.R.S. 32-1931)
  4. [4]Arizona Revised Statutes 32-1401, Definitions (paragraph 27(tt), examination before prescribing may be conducted through telehealth), accessed 2026-09-30
  5. [5]Arizona Revised Statutes 36-3601, Definitions (telehealth includes asynchronous store-and-forward technologies), accessed 2026-09-30
  6. [6]Arizona Revised Statutes 36-3602, Delivery of health care through telehealth; requirements; exceptions
  7. [7]Arizona Revised Statutes 36-3606, Interstate telehealth services; registration; requirements
  8. [8]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  9. [9]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
  10. [10]FDA: Pharmacy Compounding Advisory CommitteeFDA

Cite this page

Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.

APA style
PeptideAgent. (2026, October 28). Are peptides legal in Arizona?. https://peptideagent.ai/legal/arizona
HTML link
<a href="https://peptideagent.ai/legal/arizona">Are peptides legal in Arizona?</a>, PeptideAgent, updated October 28, 2026.